WebNov 10, 2024 · Breye Therapeutics has raised a total of €4M in funding over 2 rounds. Their latest funding was raised on Nov 10, 2024 from a Seed round. Breye Therapeutics is funded by 5 investors. Vaekstfonden and Innovation Fund Denmark are the most recent investors. Funding Rounds Number of Funding Rounds 2 Total Funding Amount €4M WebNov 10, 2024 · About Breye Therapeutics. Breye Therapeutics is a clinical stage biopharmaceutical company headquartered in Denmark pursuing a mission to develop novel oral therapies for the treatment of retinal ...
北京品易国泰科技有限公司主要人员_董事_监事 - 天眼查
WebBreye Therapeutics Inc. 37728403. Agern Alle 24, 2970 Hørsholm. Telefonnummer mangler. Obligatorisk e-mail mangler. Hjemmeside mangler. Beskrivelse. Breye Therapeutics Inc. er aktiv indenfor Fremstilling af farmaceutiske præparater (212000). Tegningsregel. Na. ... WebMr. Epstein joined Seagen as Chief Executive Officer and a member of the Board of Directors in 2024, bringing more than 30 years of drug development, deal making, commercialization and people leadership experience on a global scale. Prior to Seagen, he was executive partner at Flagship Pioneering. From 2010 to mid-2016 he served as Chief ... latin word for gateway
山东丰稻建筑工程有限公司分支机构查询 - 天眼查
WebA. AAHI AB Science Abbisko Therapeutics AbbVie Abcam Abingworth Abivax ABL Ablynx Absolute Biotech AC Immune Acacia Pharma Achilles Therapeutics ACT Genomics Actelion Acticor Biotech Actimed Therapeutics Actinium Pharmaceuticals Actinogen Medical Limited Active Biotech Adapsyn Bioscience Adaptimmune ADC Therapeutics … WebNov 10, 2024 · Breye TherapeuticsGeneral Information. Description. Developer of novel oral therapies designed for the treatment of retinal vascular diseases. The company specializes in developing de-risked, … WebNov 11, 2024 · Breye Therapeutics is a clinical stage biopharmaceutical company headquartered in Denmark pursuing a mission to develop novel oral therapies for the treatment of retinal vascular diseases. Novo Holdings A/S is a private limited liability company wholly owned by the Novo Nordisk Foundation. It is the holding company of the … latin word for gentleman